Meddi - Company finances
|
EUR
|
2022
From: 2022-01-18
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 1,082 | 2,724 | 3,350 | 6,548 |
| Profit before tax | -418 | 1,403 | 1,529 | 3,664 |
| Net profit | -418 | 1,333 | 1,453 | 3,445 |
| Equity | 582 | 2,643 | 4,096 | 5,661 |
| Liabilities | 2,208 | 0 | 4,005 | 1,900 |
| Non-current assets | 1,849 | 131 | 4,506 | 6,675 |
| Current assets | 941 | 2,512 | 801 | 886 |
| Total assets | 2,790 | 2,643 | 5,307 | 7,561 |
|
Taxes paid
|
||||
| STI taxes | - | - | 70 | 168 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +151.8% | +23.0% | +95.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -15.0% | 50.4% | 27.4% | 45.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -71.8% | 50.4% | 35.5% | 60.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -38.6% | 48.9% | 43.4% | 52.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -38.6% | 51.5% | 45.6% | 56.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.8 | - | 1.0 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Meddi - Social security debts
The company had no debts to Sodra
Meddi - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Meddi, MB (code 305984830) is a small partnership providing intermediation services for medical, dental and other human health services. In the latest financial year, 2025, the company generated revenue of €6.5K and net profit of €3.4K, resulting in a profit margin of 52.6%. Revenue increased by 95.5% year on year and by 140.4% over two years, showing a clear expansion trend from €2.7K in 2023 to €3.4K in 2024 and €6.5K in 2025. Profitability also improved over the period, with net profit rising from €1.3K in 2023 to €1.5K in 2024 and €3.4K in 2025. At the end of 2025, total assets were €7.6K, equity €5.7K and liabilities €1.9K. Long-term assets reached €6.7K, while short-term assets were €886. Key ratios indicate a strong equity position, with an equity ratio of 74.9% and debt-to-equity of 0.34, alongside asset turnover of 0.87x and return on equity of 60.9%.